Close

Pfizer (PFE) Announces FDA Approval for Remicade Biosimilar

December 13, 2017 6:02 PM EST Send to a Friend
Pfizer Inc. (NYSE: PFE) announced today that the United States (U.S.) Food and Drug Administration (FDA) has approved IXIFIâ„¢ (PF-06438179 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login